X

Trial Profile

DART Study: Anti-TNF drug utilisation and dosing patterns assessment: a retrospective chart review study of subjects treated for RA

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 02 May 2008

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Etanercept (Primary) ; Adalimumab; Infliximab; Tumour necrosis factor inhibitors
Indications Rheumatoid arthritis
Focus Therapeutic Use
Acronyms DART

Most Recent Events

22 Apr 2008 Results have been presented at British Society of Rheumatology's annual meeting in Liverpool, England.
22 Apr 2008 Status changed from in progress to completed, according to information reported in a Wyeth media release.
11 Sep 2006 New trial record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com